ATC group | International non-proprietary name | Dosage form | Number of packages sold Jan-August 2013 | Reimbursed sum (€) |
A16AB09 | Idursulfase | Sol for inf. | 87.00 | 1,092,416 |
B01AC11 | Iloprost | Nebulaser sol. | 30.00 | 23,076 |
B02BX04 | Romiplostim | Powder for sol. for inj. | 717.04 | 461,998 |
C02KX02 | Ambrisentan | Tabl film coated | 34.00 | 84,049 |
G04BE03 | Sildenafil | Tabl | 190.00 | 99,639 |
J01GB01 | Tobramycin | Nebulaser sol. | 213.00 | 488,392 |
J01GB01 | Tobramycin | Inh power, caps | 15.00 | 37,108 |
L01XE05 | Sorafenib | Film-coatedtabl. | 375.63 | 1,439,816 |
L01XE06 | Dasatinib | Film-coatedtabl. | 199.18 | 784,636 |
L01XE08 | Nilotinib | Caps. hard | 4339.21 | 3,274,735 |
L01XE09 | Temsirolimus | Conc. and solv. sol.inf. | 55.20 | 55,196 |
V03AC03 | Deferazirox | Tabldisp | 6528.00 | 2,516,615 |